CGENCOMPUGEN LTD

Nasdaq cgen.com


$ 1.89 $ -0.01 (-0.53 %)    

Monday, 22-Apr-2024 15:57:24 EDT
QQQ $ 418.61 $ 4.17 (1.01 %)
DIA $ 382.46 $ 2.57 (0.68 %)
SPY $ 499.72 $ 4.56 (0.92 %)
TLT $ 89.01 $ -0.15 (-0.17 %)
GLD $ 215.58 $ -5.46 (-2.47 %)
$ 1.89
$ 1.92
$ 0.00 x 0
$ 0.00 x 0
$ 1.88 - $ 1.96
$ 0.53 - $ 3.03
202,009
na
168.66M
$ 1.52
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 truist-securities-maintains-buy-on-compugen-raises-price-target-to-5

Truist Securities analyst Asthika Goonewardene maintains Compugen (NASDAQ:CGEN) with a Buy and raises the price target from ...

 compugen-q4-eps-011-misses-023-estimate-sales-3346m-beat-2000m-estimate

Compugen (NASDAQ:CGEN) reported quarterly earnings of $0.11 per share which missed the analyst consensus estimate of $0.23 by 5...

 earnings-scheduled-for-march-5-2024

Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2...

 earnings-preview-for-compugen
Earnings Preview For Compugen
03/04/2024 17:01:50

 stifel-maintains-buy-on-compugen-raises-price-target-to-4

Stifel analyst Stephen Willey maintains Compugen (NASDAQ:CGEN) with a Buy and raises the price target from $3 to $4.

 crude-oil-rises-over-1-biodexa-pharmaceuticals-shares-plunge

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 200 points on Tuesday. The Dow tr...

 why-compugen-shares-are-trading-higher-by-over-200-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with t...

 dow-jumps-150-points-factset-shares-rise-after-q1-results

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 150 points on Tuesday. The Dow traded up 0....

 why-is-cancer-immunotherapy-focused-compugen-stock-is-trading-higher-today

Gilead Sciences Inc (NASDAQ: GILD) announced an agreement with Compugen Ltd (NASDAQ: CGEN) to license its pre-clinical antibody...

 compugen-shares-resume-trade
Compugen Shares Resume Trade
12/19/2023 14:49:11

 us-stocks-higher-accenture-issues-weak-sales-outlook

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 50 points on Tuesday. Following the market ...

Core News & Articles

CGEN: 240% | Compugen Says It Will Be Eligible To Receive $10M Milestone Payment Upon Dosing Of First Patient In AstraZeneca Ph...

Core News & Articles

Beginning in the first quarter of 2022, consistent with recent industry communications from the U.S. Securities and Exchange Co...

Core News & Articles

Gilead will make Compugen an upfront payment of $60 million and $30 million in a near term milestone payment subject to IND cle...

 compugen-q3-eps-011-misses-009-estimate-cash-and-equivalents-575m

Compugen (NASDAQ:CGEN) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.09) by...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION